These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 377524)

  • 1. The distribution in mice of intravenously administered labelled Candida albicans.
    Trnovec T; Sikl D; Zemánek M; Faberová V; Bezek S; Gajdosík A; Koprda V
    Sabouraudia; 1978 Dec; 16(4):299-306. PubMed ID: 377524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Candida albicans infection in conventional mice and germfree rats.
    Rogers T; Balish E
    Infect Immun; 1976 Jul; 14(1):33-8. PubMed ID: 780278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of Candida albicans from kidneys of mice during short-term systemic infections.
    Baghian A; Lee KW
    Kidney Int; 1991 Sep; 40(3):400-5. PubMed ID: 1787640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between Salmonella enteritidis and Candida albicans.
    Caves JM; Carpenter JA; Hamdy MK
    Proc Soc Exp Biol Med; 1973 Jun; 143(2):433-9. PubMed ID: 4575416
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood clearance and organ localization of Candida albicans and E coli following dual infection in rats.
    Katz S; Merkel GJ; Folkening WJ; Rosenthal RS; Grosfeld JL
    J Pediatr Surg; 1993 Mar; 28(3):329-32; discussion 332-3. PubMed ID: 8468641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM; Lechner AJ
    Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ localization in mice challenged with a typical Candida albicans strain and a pseudohyphal variant.
    Evans ZA; Mardon DN
    Proc Soc Exp Biol Med; 1977 Jun; 155(2):234-8. PubMed ID: 325574
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host.
    Odds FC; Van Nuffel L; Gow NAR
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1881-1889. PubMed ID: 10931892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic candidosis in silica-treated athymic and euthymic mice.
    Lee KW; Balish E
    Infect Immun; 1983 Sep; 41(3):902-7. PubMed ID: 6309672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a murine model of systemic candidiasis with liposomal amphotericin B bearing antibody to Candida albicans.
    Hospenthal D; Gretzinger K; Rogers A
    J Med Microbiol; 1989 Nov; 30(3):193-7. PubMed ID: 2685314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains.
    Bendel CM; Kinneberg KM; Jechorek RP; Gale CA; Erlandsen SL; Hostetter MK; Wells CL
    Mol Genet Metab; 1999 Aug; 67(4):343-51. PubMed ID: 10444345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans.
    Choi JH; Ko HM; Kim JW; Lee HK; Han SS; Chun SB; Im SY
    J Immunol; 2001 Apr; 166(8):5139-44. PubMed ID: 11290796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The improved recovery of Candida albicans from fluid culture media.
    Reeder JC; Ganguli LA; Drucker DB; Keaney MG; Gibbs AC
    Microbios; 1989; 60(243):71-7. PubMed ID: 2691863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral involvement of kidneys in mice infected with Candida albicans.
    Kwon-Chung KJ; Tom WK
    Sabouraudia; 1985 Feb; 23(1):81-3. PubMed ID: 3887605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic infection with murine cytomegalovirus and Candida albicans in mice.
    Hamilton JR; Overall JC; Glasgow LA
    J Infect Dis; 1977 Jun; 135(6):918-24. PubMed ID: 193998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of germfree mice to systemic candidosis.
    Lee KW; Balish E
    J Reticuloendothel Soc; 1981 Mar; 29(3):241-8. PubMed ID: 7012339
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice.
    Kullberg BJ; van 't Wout JW; Hoogstraten C; van Furth R
    J Infect Dis; 1993 Aug; 168(2):436-43. PubMed ID: 8335982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nucleotide restriction and supplementation on resistance to experimental murine candidiasis.
    Fanslow WC; Kulkarni AD; Van Buren CT; Rudolph FB
    JPEN J Parenter Enteral Nutr; 1988; 12(1):49-52. PubMed ID: 3278158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ distribution and viability of Candida albicans in noncancerous and tumor-bearing (Lewis lung carcinoma) mice.
    Mardon DN; Robinette EH
    Can J Microbiol; 1978 Dec; 24(12):1515-9. PubMed ID: 371768
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.
    Fakhim H; Vaezi A; Dannaoui E; Chowdhary A; Nasiry D; Faeli L; Meis JF; Badali H
    Mycoses; 2018 Jun; 61(6):377-382. PubMed ID: 29460345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.